Kate Dellorusso
Stock Analyst at LifeSci Capital
(3.56)
# 2,196
Out of 4,491 analysts
19
Total ratings
66.7%
Success rate
18.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kate Dellorusso
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRNX Crinetics Pharmaceuticals | Rated: Hold | $89 → $85 | $83.50 | +1.80% | 5 | Jul 7, 2026 | |
| ACRS Aclaris Therapeutics | Initiated Coverage: Buy | $13 | $5.59 | +132.56% | 1 | Jun 1, 2026 | |
| UPB Upstream Bio | Maintained: Buy | $42 | $7.77 | +440.54% | 11 | May 19, 2026 | |
| MREO Mereo BioPharma Group | Maintained: Hold | n/a | $0.327 | - | 2 | May 12, 2026 |
Crinetics Pharmaceuticals
Jul 7, 2026
Rated: Hold
Price Target: $89 → $85
Current: $83.50
Upside: +1.80%
Aclaris Therapeutics
Jun 1, 2026
Initiated Coverage: Buy
Price Target: $13
Current: $5.59
Upside: +132.56%
Upstream Bio
May 19, 2026
Maintained: Buy
Price Target: $42
Current: $7.77
Upside: +440.54%
Mereo BioPharma Group
May 12, 2026
Maintained: Hold
Price Target: n/a
Current: $0.327
Upside: -